22157.jpg
Global Antibody Collaboration and Licensing Agreement Analysis Report 2023 with Directory of 1,812 Deals Signed Since 2016
17 nov. 2023 06h43 HE | Research and Markets
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The "Antibody Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...
Emergen logo.png
In Silico Drug Discovery Market Size Worth USD 11.68 Billion in 2032 | Emergen Research
15 nov. 2023 12h22 HE | Emergen Research
Vancouver, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The global In Silico Drug Discovery Market is forecasted to be worth USD 11.68 Billion by 2032, according to a current analysis by Emergen Research. The...
Dyadic Logo Current.jpg
Dyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
08 nov. 2023 16h00 HE | Dyadic International, Inc.
Received an upfront payment of $0.6 million in October for product development and licensing of our Dapibus™ platform for animal-free dairy enzyme productsDYAI-100 Phase 1 clinical trial top-line...
Global Bispecific Antibody Therapeutics Contract Manufacturing Market
The Global Market for Bispecific Antibody Therapeutics Contract Manufacturing 2023-2030: Driven by Demand for Innovative Therapies and Promising Results Seen in Clinical Development
06 nov. 2023 09h04 HE | Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Therapeutics Contract Manufacturing Market 2023-2030" report has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
China Bispecific Antibodies Market and Clinical Pipeline Insight Report 2023-2028: Akeso are Leading the Way and Gaining Global Recognition for their Innovative Clinical Candidates
06 nov. 2023 04h23 HE | Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "China Bispecific Antibodies Market and Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. The...
RationalStat Logo 1.png
Monoclonal Antibodies Market to Reach US$ 364 Billion by 2028, Driven by Rising Prevalence of Chronic Diseases and Technological Advancements
03 nov. 2023 07h37 HE | Rationalstat LLC
Wilmington, Delaware, Nov. 03, 2023 (GLOBE NEWSWIRE) -- According to RationalStat’s most recent industry analysis, the Global Monoclonal Antibodies Market value is US$ 196.6 billion in 2023 and is...
22157.jpg
Global CD3 Antibodies Market 2023-2028: New-Generation CD3 Antibodies Targeting Diverse Indications Gain Ground
02 nov. 2023 07h43 HE | Research and Markets
Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The "Global CD3 Antibodies Market, Dosage, Price, Sales & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. ...
Dyadic Logo Current.jpg
Dyadic to Present at Industry Events in November
30 oct. 2023 08h30 HE | Dyadic International, Inc.
Dyadic to Present at Industry Events in November
Dyadic Logo Current.jpg
Dyadic to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
25 oct. 2023 16h30 HE | Dyadic International, Inc.
JUPITER, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
TIP_link_300x300.jpg
Immunoassay Market Revenue to Cross $37.98 Billion, Globally, by 2027 - Exclusive Report by The Insight Partners
23 oct. 2023 10h43 HE | The Insight Partners
Pune, India, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Immunoassays (IAs) are bio analytical technique in which the quantitation of the analyte relies on the reaction of an antigen and an antibody....